Costs of olanzapine treatment compared with haloperidol for schizophrenia: Results from a randomized clinical trial

被引：4
|
作者：
Hamilton, SH [1 ]
Revicki, DA [1 ]
Genduso, LA [1 ]
Tollefson, GD [1 ]
机构：
[1] Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA
来源：
SCHIZOPHRENIA RESEARCH | 1998年 / 29卷 / 1-2期
关键词：
D O I：
10.1016/S0920-9964(97)88678-1
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：149 / 149
页数：1
相关论文
共 50 条
  • [21] Olanzapine Versus Haloperidol for Treatment of Delirium in Patients with Advanced Cancer: A Phase III Randomized Clinical Trial
    van der Vorst, Maurice J. D. L.
    Neefjes, Elisabeth C. W.
    Boddaert, Manon S. A.
    Verdegaal, Bea A. T. T.
    Beeker, Aart
    Teunissen, Saskia C. C.
    Beekman, Aartjan T. F.
    Wilschut, Janneke A.
    Berkhof, Johannes
    Zuurmond, Wouter W. A.
    Verheul, Henk M. W.
    ONCOLOGIST, 2020, 25 (03): : E570 - E577
  • [22] Length of hospital stay and associated costs for olanzapine vs. haloperidol in the treatment of schizophrenia in Germany
    Spannheimer, A
    Reitberger, U
    Clouth, J
    Lothgren, M
    SCHIZOPHRENIA RESEARCH, 2002, 53 (03) : 178 - 178
  • [23] Sex differences in clinical response to olanzapine compared with haloperidol
    Goldstein, JM
    Cohen, LS
    Horton, NJ
    Lee, H
    Andersen, S
    Tohen, M
    Crawford, AMK
    Tollefson, G
    PSYCHIATRY RESEARCH, 2002, 110 (01) : 27 - 37
  • [24] Haloperidol, olanzapine and risperidone reduce treatment failure compared to aripiprazole, quetiapine and ziprasidone in acute schizophrenia
    Taylor, David
    EVIDENCE-BASED MENTAL HEALTH, 2007, 10 (03) : 76 - 76
  • [25] Olanzapine, risperidone and haloperidol in the treatment of adolescent patients with schizophrenia
    D. Gothelf
    A. Apter
    J. Reidman
    A. Brand-Gothelf
    Y. Bloch
    G. Gal
    L. Kikinzon
    S. Tyano
    R. Weizman
    G. Ratzoni
    Journal of Neural Transmission, 2003, 110 : 545 - 560
  • [26] Olanzapine, risperidone and haloperidol in the treatment of adolescent patients with schizophrenia
    Gothelf, D
    Apter, A
    Reidman, J
    Brand-Gothelf, A
    Bloch, Y
    Gal, G
    Kikinzon, L
    Tyano, S
    Weizman, R
    Ratzoni, G
    JOURNAL OF NEURAL TRANSMISSION, 2003, 110 (05) : 545 - 560
  • [27] Efficacy and safety of olanzapine versus haloperidol in the treatment of BPSD: New data from a clinical trial
    Verkaaik, M
    Verhey, F
    Lousberg, R
    INTERNATIONAL PSYCHOGERIATRICS, 2005, 17 : 174 - 174
  • [28] Effectiveness of Paliperidone Palmitate vs Haloperidol Decanoate for Maintenance Treatment of Schizophrenia A Randomized Clinical Trial
    McEvoy, Joseph P.
    Byerly, Matthew
    Hamer, Robert M.
    Dominik, Rosalie
    Swartz, Marvin S.
    Rosenheck, Robert A.
    Ray, Neepa
    Lamberti, J. Steven
    Buckley, Peter F.
    Wilkins, Tania M.
    Stroup, T. Scott
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 311 (19): : 1978 - 1986
  • [29] The GiSAS study: Rationale and design of a pragmatic randomized controlled trial on aripiprazole, olanzapine and haloperidol in the long-term treatment of schizophrenia
    Parabiaghi, Alberto
    D'Avanzo, Barbara
    Tettamanti, Mauro
    Barbato, Angelo
    CONTEMPORARY CLINICAL TRIALS, 2011, 32 (05) : 675 - 684
  • [30] Olanzapine versus haloperidol in the treatment of agitation in elderly patients with dementia: Results of a randomized controlled double-blind trial
    Verhey, FRJ
    Verkaaik, M
    Lousbert, R
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2006, 21 (01) : 1 - 8
12345